Neuropace
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuropace and other ETFs, options, and stocks.About NPCE
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads.
CEOJoel D. Becker
CEOJoel D. Becker
Employees209
Employees209
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded1997
Founded1997
Employees209
Employees209
NPCE Key Statistics
Market cap456.86M
Market cap456.86M
Price-Earnings ratio-20.55
Price-Earnings ratio-20.55
Dividend yield—
Dividend yield—
Average volume261.30K
Average volume261.30K
High today—
High today—
Low today—
Low today—
Open price$13.72
Open price$13.72
Volume0.00
Volume0.00
52 Week high$18.98
52 Week high$18.98
52 Week low$7.56
52 Week low$7.56
Stock Snapshot
The current Neuropace(NPCE) stock price is $13.56, with a market capitalization of 456.86M. The stock trades at a price-to-earnings (P/E) ratio of -20.55.
During the trading day, Neuropace(NPCE) stock saw an opening price of $13.72, a peak of —, and a bottom of —.
Trading volume for Neuropace(NPCE) stock has reached 0, versus its average volume of 261.3K.
The stock's 52-week range extends from a low of $7.56 to a high of $18.98.
The stock's 52-week range extends from a low of $7.56 to a high of $18.98.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NPCE. This list is generated using Robinhood data, and it’s not a recommendation.